NOVA Group Holdings Battles Post-Pandemic Struggles
Novartis Group Announces Appointment of Tianjian as New Auditor
Nuofa Group (01360) announced that Hengjian Certified Public Accountants Co., Ltd. has resigned as the company's auditor with effect from April 11, 2024. The Group has appointed Hengjian as its auditor for many years. However, due to the restructuring of Hengjian and Tianjian International Certified Public Accountants Limited, after considering the recommendations of the Company's Audit Committee, the board of directors has decided to appoint Tianjian as the company's new auditor with effect from April 11, 2024 to fill the temporary vacancy caused by Heng Jian's resignation. The term of office is until the end of the company's next annual general meeting of shareholders, thus ensuring the provision of consistent and efficient audit services to the company.
NOVA Group Hires New Auditor
Novartis Group (01360) appoints Tianjian as new auditor
Nuofa Group (01360) announced that Hengjian Certified Public Accountants Co., Ltd. has resigned as the company's auditor since 2024...
Novartis Group (01360.HK) receives additional trading resumption guidelines from the Stock Exchange
Novartis Group (01360.HK) announced that the Company received a letter from the Stock Exchange on March 27, 2024. According to this, the Stock Exchange has issued additional trading guidelines to the Company
NOVA GROUP: 2023/24 INTERIM REPORT
Nova Group Shrinks Loss in Fiscal H1
Novartis Group (01360.HK)'s interim revenue of approximately HK$6 million decreased by about 80.2% year over year
Glonghui, Feb. 27丨Novartis Group (01360.HK) announced that in its interim results for the six months ended December 31, 2023, the Group has recorded revenue of about HK$6 million, a decrease of about 80.2% compared to about HK$30.4 million in the same period last year. Operating losses during the reporting period were approximately HK$4.9 million, a decrease of about 98.4% compared with operating losses of approximately HK$316 million in the same period last year. The net loss for the reporting period was approximately HK$7.2 million, down about 97.8% from the net loss of approximately HK$329.6 million in the same period last year. The decrease in net loss was mainly due to confirmed goodwill impairment losses of approximately 1.286 in the same period last year
NOVA GROUP: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 31 DECEMBER 2023
Novartis Group (01360.HK): Group business operations continue as usual and trading continues to be suspended
Gelonghui, January 2, 丨 Novartis Group (01360.HK) announced that in November 2023, the Group will respond to the HKSAR Government's call to revitalize the local consumer economy and launch a new clubhouse business in Central, Hong Kong, targeting entertainment and alcohol customers. The new business is expected to contribute revenue to the Group in the first half of this fiscal year. Despite the suspension of trading of the company's shares, all aspects of the Group's business operations are carried out as usual. Trading of the Company's shares on the Stock Exchange was suspended at 9:00 a.m. on October 3, 2023, and will remain suspended until further notice.
Novartis Group received instructions to resume trading and continued to suspend trading
Novartis Group (01360) issued an announcement. On December 14, 2023, the company has received a letter from the Stock Exchange containing guidelines for the resumption of trading of the following companies' shares on the Stock Exchange: (a) According to the requirements of section 13.50A of the listing rules, the company's accountants did not express an opinion on the company's financial statements for the year ended June 30, 2023. Indeed, there is no need to issue no more comments and disclose sufficient information so that investors can evaluate the company's financial situation with an informed understanding; (b) Conduct an independent internal control review to prove that the company has been established enough Internal controls and procedures to comply
Novartis Group (01360.HK) received guidance from the Stock Exchange to resume trading
Glonghui, December 19|Novartis Group (01360.HK) announced that on December 14, 2023, the company has received a letter from the Stock Exchange setting out the guidelines for the resumption of trading of the following company shares on the Stock Exchange (Resumption Guidelines): (a) In accordance with the requirements of section 13.50A of the listing rules, which caused the company's accountants not to comment on the company's financial statements for the year ended June 30, 2023. Indeed, there is no need to issue no more comments and disclose sufficient information for investors to make an informed assessment of the company's financial situation; (b) Proceed Independent internal control review to certify the company
Nuofa Group (01360.HK): Huang Qian resigns as non-executive director
On November 2, Gelonghui Group (01360.HK) announced that Huang Qian has resigned as the company's non-executive director due to her plans to invest more time in other businesses, effective November 2, 2023.
NOVA GROUP: Annual Report 2022/23
Novartis Group announced the suspension of trading from the morning of October 3
Nofa Group (01360) announced that trading of the company's shares will be suspended from 9:00 a.m. on October 3, 2023.
Novartis Group (01360.HK) suspended trading this morning
GLONGHUI, Oct. 3 | Novartis Group (01360.HK) announced that trading of the company's shares will be suspended starting at 9:00 a.m. today (3/10/2023).
Nova Group Holdings' Fiscal Year 2023 Attributable Loss Widens as Revenue Plunges
Novartis Group (01360) announced annual results, with a net loss of HK$506 million, an increase of 312.2% over the previous year
Nova Group (01360) announced its results for the year ended June 30, 2023, with total revenue of 41.229 million...
NOVA GROUP: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 30 JUNE 2023
The board meeting of Novartis Group (01360.HK) will be postponed until September 29
GLONGHUI September 21丨Novartis Group (01360.HK) announced that due to the need for more time to implement the 2023 annual results, the board meeting will be postponed until September 29, 2023.
No Data